Great strides have been made in the understanding of anatomy, physiology, pathology, diagnosis, and treatment of pituitary adenomas. The single greatest credit should probably be given to the rapid advancement in surgical techniques that ushered in a new era of multispecialty interest in the pituitary and its disorders. The fate of patients with pituitary adenomas was thus greatly improved. Surgical treatment can offer a cure in a vast majority of patients. The morbidity and mortality following transsphenoidal surgery are low. In patients with certain hormonally active pituitary macroadenomas, multidisciplinary therapy including pre- and postoperative medical management with bromocriptine and postoperative radiation therapy have decreased the recurrence rate to a respectable 10 per cent.
在垂体腺瘤的解剖学、生理学、病理学、诊断和治疗方面已经取得了巨大进展。这其中最大的功劳或许应归功于手术技术的迅速进步,它开启了多学科关注垂体及其疾病的新时代。垂体腺瘤患者的命运因此得到了极大改善。手术治疗能使绝大多数患者治愈。经蝶窦手术的发病率和死亡率都很低。对于某些有激素活性的垂体大腺瘤患者,包括术前和术后使用溴隐亭进行药物治疗以及术后放疗的多学科治疗,已将复发率降低到了可观的10%。